RxDoctor Payments Data

John Germiller

Otolaryngology · Philadelphia, PANPI 1104916121

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,444 of the $5,656 with a category attached, or 96.2%. Lilly USA, LLC accounts for 96.2% of it on its own, with 1 other manufacturer making up the rest.

$5,656in general payments, 2019–2025

Across 8 payments — averaging $707.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$5K
  • Eli Lilly$212
$819,832in research payments, 2019–2025

Across 45 payments — averaging $18,218 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$486K
  • Cochlear Americas$328K
  • Upjohn US 1 LLC$6K

What the payments were for

  • Consulting fees$5,44496%
  • Travel & lodging$1082%
  • Food & beverage$1042%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Lilly USA, LLC5$5,444
Eli Lilly3$212

How this compares

$5,656 in reported general payments places this provider in the 85th percentile of 456 otolaryngology providers in Pennsylvania.

See all otolaryngology providers in Pennsylvania

Other otolaryngology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →